Skip to search formSkip to main contentSkip to account menu

NSC 65346

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

sangivamycin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells
Nilotinib does not significantly reduce imatinib OCT-1 activity in either cell lines or primary CML cells 
2009
2009
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC
BackgroundThe nucleoside analog, ARC (NSC 188491) is a recently characterized transcriptional inhibitor that selectively kills… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)